Technical Analysis for AURA - Aura Biosciences, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Doji - Bullish? | Reversal | 0.00% | |
Fell Below 20 DMA | Bearish | 0.97% | |
MACD Bearish Signal Line Cross | Bearish | 0.97% | |
Bollinger Band Squeeze | Range Contraction | 0.97% | |
Gapped Down | Weakness | 0.97% | |
50 DMA Resistance | Bearish | -3.07% | |
20 DMA Support | Bullish | -3.07% | |
Bollinger Band Squeeze | Range Contraction | -3.07% | |
BB Squeeze + Upper Band Touch | Range Contraction | -3.07% |
Alert | Time |
---|---|
Fell Below Previous Day's Low | 1 day ago |
Down 2 % | 1 day ago |
Down 1% | 1 day ago |
Up 2% | 1 day ago |
Up 1% | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/29/2024
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. The company also develops AU-011 in additional ocular oncology indications, including choroidal metastases. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 13.5 |
52 Week Low | 5.9906 |
Average Volume | 196,625 |
200-Day Moving Average | 8.57 |
50-Day Moving Average | 7.54 |
20-Day Moving Average | 7.40 |
10-Day Moving Average | 7.41 |
Average True Range | 0.41 |
RSI (14) | 45.95 |
ADX | 18.12 |
+DI | 24.02 |
-DI | 17.43 |
Chandelier Exit (Long, 3 ATRs) | 6.88 |
Chandelier Exit (Short, 3 ATRs) | 8.10 |
Upper Bollinger Bands | 7.86 |
Lower Bollinger Band | 6.94 |
Percent B (%b) | 0.36 |
BandWidth | 12.45 |
MACD Line | -0.06 |
MACD Signal Line | -0.05 |
MACD Histogram | -0.007 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 7.88 | ||||
Resistance 3 (R3) | 7.85 | 7.62 | 7.78 | ||
Resistance 2 (R2) | 7.62 | 7.47 | 7.64 | 7.74 | |
Resistance 1 (R1) | 7.45 | 7.37 | 7.54 | 7.47 | 7.71 |
Pivot Point | 7.22 | 7.22 | 7.26 | 7.23 | 7.22 |
Support 1 (S1) | 7.04 | 7.06 | 7.13 | 7.07 | 6.83 |
Support 2 (S2) | 6.81 | 6.97 | 6.83 | 6.80 | |
Support 3 (S3) | 6.64 | 6.81 | 6.76 | ||
Support 4 (S4) | 6.66 |